Skip to main content

Child Malnutrition

0
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Vera Therapeutics
Vera TherapeuticsBRISBANE, CA
1 program
Provision of information on safe waterN/A1 trial
Active Trials
NCT02427945CompletedEst. Jun 2017
ViiV Healthcare
ViiV HealthcareNC - Durham
1 program
Topical emollientN/A
GSK
GSKLONDON, United Kingdom
1 program
Topical emollientN/A1 trial
Active Trials
NCT02616289Completed212Est. Dec 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GSKTopical emollient
Vera TherapeuticsProvision of information on safe water

Clinical Trials (2)

Total enrollment: 212 patients across 2 trials

NCT02616289GSKTopical emollient

Emollient Therapy for Severe Acute Malnutrition

Start: Jan 2016Est. completion: Dec 2019212 patients
N/ACompleted
NCT02427945Vera TherapeuticsProvision of information on safe water

Leveraging an Existing Large-scale Safe Water Program to Deliver Nutrition Messages at a Low Marginal Cost

Start: May 2015Est. completion: Jun 2017
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.